Finance

Lists
688117:SHA
ChengDu Sheng Nuo Biotec Co Ltd
CNÂ¥23.74
+0.76%
(+0.18) 1D
Sep 8, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688117...
Open
CNÂ¥23.61
High
CNÂ¥23.89
Low
CNÂ¥23.32
Mkt. cap
5.19B
Avg. vol.
7.98M
Volume
4.43M
Dividend
1.06%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jun 5, 2026
P/E ratio
25.72
52-wk high
CNÂ¥33.21
52-wk low
CNÂ¥20.91
EPS
CNÂ¥0.92
No. of employees
2K
Open
CNÂ¥23.61
High
CNÂ¥23.89
Low
CNÂ¥23.32
Mkt. cap
5.19B
Avg. vol.
7.98M
Volume
4.43M
Dividend
1.06%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jun 5, 2026
P/E ratio
25.72
52-wk high
CNÂ¥33.21
52-wk low
CNÂ¥20.91
EPS
CNÂ¥0.92
No. of employees
2K
About ChengDu Sheng Nuo Biotec Co Ltd
CEO-
Employees1.83K
FoundedJul 23, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
182.55M
221.34M
244.29M
262.98M
Cost of goods sold
71.21M
103.50M
98.04M
117.41M
Cost of revenue
71.21M
103.50M
98.04M
117.41M
Research and development expenses
18.22M
18.55M
10.85M
13.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.40M
43.94M
46.95M
47.82M
Operating expense
47.73M
74.26M
61.38M
63.69M
Total operating expenses
118.95M
177.75M
159.41M
181.11M
Operating income
63.60M
43.58M
84.87M
81.87M
Other non operating income
-5.93M
-607.69K
370.80K
12.26K
EBT including unusual items
42.96M
43.45M
75.98M
81.39M
EBT excluding unusual items
52.37M
40.47M
80.73M
76.03M
Income tax expense
4.91M
12.53M
9.62M
12.56M
Effective tax rate
11.42%
28.85%
12.66%
15.43%
Other operating expenses
-1.19M
2.99M
1.81M
2.76M
Net income
38.05M
30.91M
66.36M
68.83M
Net profit margin
20.85%
13.97%
27.17%
26.17%
Earnings per share
-
-
-
-
Interest and investment income
107.91K
1.12M
1.94M
1.55M
Interest expense
-5.22M
-2.86M
-6.45M
-3.47M
Net interest expenses
-5.11M
-1.75M
-4.51M
-1.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
72.00M
57.56M
98.85M
100.81M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps